Propranolol: A 50-year historical perspective
Propranolol is a beta-adrenergic receptor antagonist that was developed by the British scientist Sir James Black primarily for the treatment of angina pectoris, more than 50 years ago. It was not long before several other cardiovascular as well as noncardiovascular therapeutic uses of propranolol we...
Main Author: | A V Srinivasan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Annals of Indian Academy of Neurology |
Subjects: | |
Online Access: | http://www.annalsofian.org/article.asp?issn=0972-2327;year=2019;volume=22;issue=1;spage=21;epage=26;aulast=Srinivasan |
Similar Items
-
An alternative synthesis of (+) - propranolol and (+) – atenolol
by: Aphiwat Teerawutgulrag
Published: (2012-10-01) -
Low-Dose Propranolol Prevents Functional Decline in Catecholamine-Induced Acute Heart Failure in Rats
by: Cheng-Ken Tsai, et al.
Published: (2022-05-01) -
Oral atenolol versus propranolol in the treatment of infantile hemangioma: A systematic review and meta-analysis
by: Swapnil Annasaheb Pattanshetti, et al.
Published: (2022-01-01) -
Infantile Hemangioma Treated with Oral Propranolol: Case Presentation
by: Raufi N, et al.
Published: (2021-08-01) -
Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial
by: Luca Filippi, et al.
Published: (2017-07-01)